Literature DB >> 28330972

Fatal Cerebral Edema With Status Epilepticus in Children With Dravet Syndrome: Report of 5 Cases.

Kenneth A Myers1,2, Jacinta M McMahon1, Simone A Mandelstam3,4,5, Mark T Mackay5,6, Renate M Kalnins7, Richard J Leventer3,6,8, Ingrid E Scheffer9,3,5,6.   

Abstract

Dravet syndrome (DS) is a well-recognized developmental and epileptic encephalopathy associated with SCN1A mutations and 15% mortality by 20 years. Although over half of cases succumb to sudden unexpected death in epilepsy, the cause of death in the remainder is poorly defined. We describe the clinical, radiologic, and pathologic characteristics of a cohort of children with DS and SCN1A mutations who developed fatal cerebral edema causing mass effect after fever-associated status epilepticus. Cases were identified from a review of children with DS enrolled in the Epilepsy Genetics Research Program at The University of Melbourne, Austin Health, who died after fever-associated status epilepticus. Five children were identified, all of whom presented with fever-associated convulsive status epilepticus, developed severe brain swelling, and died. All had de novo SCN1A mutations. Fever of 40°C or greater was measured in all cases. Signs of brainstem dysfunction, indicating cerebral herniation, were first noted 3 to 5 days after initial presentation in 4 patients, though were apparent as early as 24 hours in 1 case. When MRI was performed early in a patient's course, focal regions of cortical diffusion restriction were noted. Later MRI studies demonstrated diffuse cytotoxic edema, with severe cerebral herniation. Postmortem studies revealed diffuse brain edema and widespread neuronal damage. Laminar necrosis was seen in 1 case. Cerebral edema leading to fatal brain herniation is an important, previously unreported sequela of status epilepticus in children with DS. This potentially remediable complication may be a significant contributor to the early mortality of DS.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28330972     DOI: 10.1542/peds.2016-1933

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

Review 1.  Sudden death in epilepsy: There is room for intracranial pressure.

Authors:  Maxine Dibué; Jochem K H Spoor; Marjolein Dremmen; Christiane Freiin von Saß; Daniel Hänggi; Hans-Jakob Steiger; Philippe Ryvlin; Marcel A Kamp
Journal:  Brain Behav       Date:  2020-09-19       Impact factor: 2.708

2.  Etiology of Non-Traumatic Seizures in Children Admitted to PICU: An Eight-Year Retrospective Study.

Authors:  Xiaolu Deng; Fang He; Ciliu Zhang; Fei Yin; Jing Peng
Journal:  Int J Gen Med       Date:  2020-11-26

Review 3.  Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe.

Authors:  Elena Cardenal-Muñoz; Stéphane Auvin; Vicente Villanueva; J Helen Cross; Sameer M Zuberi; Lieven Lagae; José Ángel Aibar
Journal:  Epilepsia Open       Date:  2021-12-19

4.  Fatal Pediatric COVID-19 Case With Seizures and Fulminant Cerebral Edema.

Authors:  Siddharth Ninan; Peyton Thompson; Timothy Gershon; Natalie Ford; William Mills; Valerie Jewells; Leigh Thorne; Katherine Saunders; Thomas Bouldin; Jason R Smedberg; Melissa B Miller; Eveline Wu; Alyssa Tilly; Jeremy Sites; Daniel Lercher; Katherine Clement; Tracie Walker; Paul Shea; Benny Joyner; Rebecca Smith
Journal:  Child Neurol Open       Date:  2021-06-14

5.  Can the combination of hyperthermia, seizures and ion channel dysfunction cause fatal post-ictal cerebral edema in patients with SCN1A mutations?

Authors:  Carina Büren; Marcel Alexander Kamp; Christopher Munoz-Bendix; Hans-Jakob Steiger; Joachim Windolf; Maxine Dibué-Adjei
Journal:  Epilepsy Behav Case Rep       Date:  2017-12-24

Review 6.  Predicting the impact of sodium channel mutations in human brain disease.

Authors:  Jeffrey L Noebels
Journal:  Epilepsia       Date:  2019-12       Impact factor: 5.864

7.  Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.

Authors:  Ian Miller; Ingrid E Scheffer; Boudewijn Gunning; Rocio Sanchez-Carpintero; Antonio Gil-Nagel; M Scott Perry; Russell P Saneto; Daniel Checketts; Eduardo Dunayevich; Volker Knappertz
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

8.  Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.

Authors:  Wenhui Li; Amy L Schneider; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2021-08-02       Impact factor: 6.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.